tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market

Inhibikase Therapeutics (IKT) Technical Analysis

Compare
384 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Inhibikase Therapeutics is a Buy.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 1.86, while Inhibikase Therapeutics’s (IKT) share price is $1.89, making it a Buy.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.77, while Inhibikase Therapeutics’s (IKT) share price is $1.89, making it a Buy.

Inhibikase Therapeutics (IKT) Pivot Points

Mar 11, 2026, 10:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.68
1.75
1.82
1.89
1.96
2.03
2.10
Fibonacci
1.75
1.81
1.84
1.89
1.95
1.98
2.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inhibikase Therapeutics (IKT) Moving Averages

Mar 11, 2026, 10:27 AM
Period
Simple
Exponential
MA5
1.90Sell
1.91Sell
MA10
1.98Sell
1.91Sell
MA20
1.84Buy
1.86Buy
MA50
1.78Buy
1.77Buy
MA100
1.67Buy
1.73Buy
MA200
1.71Buy
1.79Buy
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.91, while Inhibikase Therapeutics’s (IKT) share price is $1.89, making it a Sell.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.73, while Inhibikase Therapeutics’s (IKT) share price is $1.89, making it a Buy.
Inhibikase Therapeutics’s (IKT) stock price is $1.89 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.78, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.89 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.67, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.89 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.71, creating a Buy signal.

Inhibikase Therapeutics (IKT) Technical Indicators

Mar 11, 2026, 10:27 AM
Name
Value
Implied Action
RSI (14)
53.86
Neutral
STOCH (9,6)
21.47
Neutral
STOCHRSI (14)
37.71
Neutral
MACD (12,26)
0.06
Buy
ADX (14)
28.54
Neutral
Williams %R
-64.91
Buy
CCI (14)
10.34
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
43.85
Neutral
ROC
11.83
Buy
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 53.86, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 28.54, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is 10.34, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is 11.83, creating a Buy signal.

FAQ

Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Buy.
    What is IKT’s RSI (14)?
    IKT’s RSI (14) is 53.86, which suggests IKT is a Neutral.
      What is IKT’s MACD?
      IKT’s MACD is 0.06, which suggests IKT is a Buy.
        What is IKT’s 5-day moving average?
        IKT’s 5-day moving average is 1.90, which suggests IKT is a Sell.
          What is IKT’s 20-day moving average?
          IKT 20-day moving average is 1.84, which suggests IKT is a Buy.
            What is IKT’s 50-day moving average?
            IKT’s 50-day moving average is 1.78, which suggests IKT is a Buy.
              What is IKT’s 200-day moving average?
              IKT’s 200-day moving average is 1.71, which suggests IKT is a Buy.
                What is IKT’s Williams % R (14)?
                IKT’s Williams % R (14) is -64.91, which suggests IKT is a Buy.
                  What is IKT’s CCI (14)?
                  IKT’s CCI (14) is 10.34, which suggests IKT is a Neutral.